We are live on ! Find out more
BLFS icon

BioLife Solutions
BLFS

49 hedge funds and large institutions have $51.9M invested in BioLife Solutions in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,900% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 1

501% more capital invested

Capital invested by funds: $8.62M → $51.9M (+$43.2M)

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

63% more funds holding

Funds holding: 30 → 49 (+19)

18.18% more ownership

Funds ownership: 11.9% → 30.09% (+18%)

Holders
49
Holders Change
+19
Holders Change %
+63.33%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
16
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Casdin Capital
New York
+$9.1M
2
VCM
Venator Capital Management
Ontario, Canada
+$4.27M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.63M
4
SCM
Sandler Capital Management
New York
+$1.38M
5
PCM
Perkins Capital Management
Minnesota
+$1.19M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$802K
2
KIA
Kopp Investment Advisors
Minnesota
-$152K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$151K
4
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$33.1K
5
IA
IFP Advisors
Florida
-$6.69K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$274K +$62.3K +6,838 +40%
VF
27
Virtu Financial
New York
$245K +$196K +21,492 New
Citadel Advisors
28
Citadel Advisors
Florida
$194K +$54.1K +5,946 +54%
Northern Trust
29
Northern Trust
Illinois
$186K +$29.1K +3,200 +24%
SKK
30
Shepherd Kaplan Krochuk
Massachusetts
$183K +$146K +16,000 New
Jane Street
31
Jane Street
New York
$173K +$138K +15,181 New
Two Sigma Advisers
32
Two Sigma Advisers
New York
$139K +$111K +12,200 New
First Manhattan
33
First Manhattan
New York
$136K – – –
O
34
OppenheimerFunds
New York
$130K +$104K +11,429 New
KA
35
Kovack Advisors
Florida
$126K +$101K +11,075 New
EMG
36
Ellington Management Group
Connecticut
$122K +$97.4K +10,700 New
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
$114K – – –
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$114K +$91.6K +10,064 New
Macquarie Group
39
Macquarie Group
Australia
$88K +$70.1K +7,700 New
UBS Group
40
UBS Group
Switzerland
$32K +$7.13K +783 +39%
Morgan Stanley
41
Morgan Stanley
New York
$10K +$7.29K +801 +2,427%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$6K -$109 -12 -2%
Federated Hermes
43
Federated Hermes
Pennsylvania
$4K +$2.85K +313 New
TRCT
44
Tower Research Capital (TRC)
New York
$4K +$3.06K +336 +5,600%
Bank of America
45
Bank of America
North Carolina
$3K +$1.96K +215 +1,433%
KIA
46
Kopp Investment Advisors
Minnesota
– -$152K -29,600 Closed
IA
47
IFP Advisors
Florida
– -$6.69K -735 -96%
1
2

BLFS Hedge Fund Activity: Q2 2018 in Review

49 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2018, worth a combined $51.9M — up 501% from $8.62M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BLFS positions and 1 closed out — a net gain of 19 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Casdin Capital, opening a new position worth an estimated $9.1M. The largest seller was Millennium Management, cutting an estimated $802K.

  • 49 institutional investors held BioLife Solutions (BLFS) as of Q2 2018, up from 30 in Q1 2018.
  • Funds reported $51.9M of BioLife Solutions stock for Q2 2018, up 501% quarter-over-quarter.
  • 20 funds opened new BioLife Solutions positions in Q2 2018 and 1 closed out, a net change of +19 holders.
  • The largest BioLife Solutions buyer in Q2 2018 was Casdin Capital, an estimated $9.1M added.
  • The largest BioLife Solutions seller in Q2 2018 was Millennium Management, an estimated $802K sold.

Based on aggregated 13F filings for Q2 2018.